Th is report is aimed at describing a pericardial patch for unresectable cardiac tumors as a palliative technique to prevent pleural effusion.
INTRODUCTION
Cardiac tumors are atypical diseases in the feline and canine population and are often described as incidental fi ndings [1] . The most common types include haemangiosarcoma (HSA), aortic body tumors (chemodectoma and paraganglioma) and lymphoma [2] .
Cardiac tumors ideally require surgical treatment, with the aim of removing all the neoplastic tissue, and, associated systemic drug therapy [3] . Alternatively, external beam radiotherapy was recently used in a dog affected by chemodectoma [4] .
In cases of unremovable lesions, palliative pericardiectomy has usually been recommended in order to avoid any potential cardiac tamponade and consequent pleural effusions [3] [4] [5] .
Pericardiectomy has been associated with prolonged survival in dogs with aortic body tumors, but this approach does not slow tumor growth or improve cardiovascular function in dogs with compressive tumors [6, 7] .
In cases of pleural effusions occurring after pericardiectomy, further palliative treatments may be used such as recurring thoracentesis and pleural port application; recently the insertion of self-expanding stents into the cranial cave vein has been described [8] .
We hypothesized that the pericardium may be used as a patch on the cardiac mass to reduce the pleural effusion.
The aim of this study is to describe the application of a pericardial patch in three dogs affected by unresectable cardiac tumors as a palliative treatment to reduce pleural effusions.
CASE DESCRIPTION
Three dogs (12- year-old entire male German Shepherd, 10-year-old entire male Labrador Retriever, and 10-year-old neutered female Pug) were each presented with a history of exercise intolerance, lethargy, jugular venous distension, and weight loss. On physical examination muffl ed heart sounds were present.
Each dog underwent the same diagnostic protocol including a cardiological assessment, hematology and biochemistry profi le, urinary test, abdominal and heart ultrasonography and thoracic radiographs.
A suspicion of cardiac mass presence was observed. Echocardiography revealed a right atrial mass in two dogs (German Shepherd and Labrador Retriever) and a body aortic mass in the third (Pug). After full staging consisting of blood work, urine examination of total body computed tomography was always performed: no metastatic lesions were observed and all masses were considered unresectable ( Fig.1 ).
According to a presumptive diagnosis based on anatomical location, a biopsy of the mass and pericardial patch application was proposed to the owners as a palliative surgical treatment in order to reduce the pericardial and pleural effusions.
The dogs were sedated with morphine (0.2 mg/kg IM) and acepromazine (0.05 mg/ kg IM) 20 min before induction. After preoxygenation for 5 minutes, anesthesia was induced with propofol (4 mg/kg [1.8 mg/lb], IV). Lactated Ringer's solution (2 mL/ kg/h) was administered IV to maintain normovolemia, and cefazoline (20 mg/kg, IV) was administered at induction and every 120 min throughout the procedure. Dogs were then intubated with a cuffed endotracheal tube and a stable level of anesthesia was achieved with sevofl urane and oxygen.
Surgical technique
Each patient was positioned in left recumbency; a right thoracotomy performed at the fi fth intercostal space was performed. An intercostal retractor was applied between the ribs to expose the thoracic cavity. The lungs were gently retracted using laparotomic swabs.
A T-shaped pericardial incision was performed ventrally to the phrenic nerve. The short side of the T-shaped incision was always parallel to the phrenic nerve while the longer incision was achieved according to the mass position ( Fig. 2) . Following the incision (Fig. 3) , the pericardium was transposed in order to cover the mass according to its shape and then sutured with a 4-0 monofi lament absorbable continuous suture pattern (Fig. 4) . A 6 mm punch was used to achieve a biopsy of the mass.
The thoracic cavity was then fl ushed with a warm sterile solution.
An active chest tube drain was applied and the thoracotomy site was routinely closed.
Negative pressure was then achieved using the drain. A soft bandage was applied around the chest.
Postoperative care
Following surgery, the dogs recovered under close supervision in the intensive care unit. Post-operative medication included methadone (0.2 mg/kg IM every 4-6 hours), intravenous cefazolin (22 mg/kg every 8 hours until the dog accepted oral antibiotics) and continuous intravenous 0.9% NaCl crystalloid therapy. Respiratory rate and effort were monitored. The drain was removed when the postoperative pleural effusion was lower than 2 ml/ kg/die. Following drain removal, dogs were discharged with oral medications including amoxicillin/clavulanic acid (20 mg/kg PO every 12 hours) and tramadol (2-4 mg/kg PO every 8 hours) for up to 7 days after surgery.
There were no major intraoperative complications. Surgical times were 40, 50 and 45 minutes respectively. Histological assessment of the masses revealed HSA in the German Shepherd and Labrador and chemodectoma in the Pug.
Chemotherapy protocol included doxorubicin that was administered through an indwelling intravenous catheter at the dose of 30 mg/m 2 . X-ray re-examination was performed 30, 60 days post-operatively. No pleural effusion was seen from any of the three dogs.
The dogs with HSA survived 65 and 80 days respectively without pleural effusion, while the last died after six months for reasons unrelated to the tumour. The goal of the palliative treatment in dogs affected by unresectable heart tumors is to reduce the pericardial effusion. Pleural effusions may additionally develop which can lead to respiratory involvement, pericardial tamponade, and death [9, 10] .
Pericardiectomy is a surgical procedure aimed to remove the pericardial sac. Neoplastic pericardial effusions may be treated by subtotal pericardiectomy via thoracotomy or by a thoracoscopic pericardial window [11] . Surgeons observed that idiopathic pericardial effusion treated with a subtotal pericardiectomy performed using a thoracotomic approach was associated with a longer disease-free interval (DFI) and medial survival time (MST) in comparison to those treated using a thoracoscopic pericardial window [11] .
For these reasons, we approached the unresectable heart tumors described in this paper via thoracotomy. The pericardial patch was performed, by applying it onto the mass, without removing the pericardium. Firstly, it is aimed to treat the pericardial effusion as a pericardiectomy by a dorsocaudal transposition of the pericardium, and secondly, to reduce the pleural effusion by a mechanical compression achieved by suturing the pericardium onto the mass.
The pericardial patch was always obtained following a T-shaped pericardial incision. In those patients affected by haemangiosarcoma of the right atrium, the long side of the T-shaped incision was cranially performed in order to cover the mass located in the caudal heart, and in the patient with chemodectoma, the long side of T-shaped incision was caudally performed in order to cover the mass located on the base of the heart.
Re-examination of the three dogs showed no further pleural effusions: dogs affected by HSA died 65 and 80 days post-surgery with pulmonary and hepatic metastasis, while the dog affected by chemodectoma died six months after surgery following a road traffi c accident.
Surgical treatment of chronic pleural effusion includes pleuroperitoneal shunting, pleurovenous shunting, pleural port and omentalization of the pleural space [12] [13] [14] [15] .
All these procedures require the application of pleural port devices or a second lateral abdominal approach.
The pericardial patch may potentially enable concurrent treatment of the pericardial effusion and the consequential pleural effusion by a single thoracotomic approach.
The surgical procedure was easy to perform without evidence of any intraoperative/ postoperative complications.
According to the preliminary results, the pericardial patch is a potential choice as a palliative treatment for unresectable cardiac tumors, however, considering the small sample size within this study, further studies would be strongly encouraged for a better understanding of the potential indication of this treatment.
